Your browser doesn't support javascript.
loading
SIU-ICUD on bladder cancer: pathology.
Compérat, Eva; Babjuk, Marek; Algaba, Ferran; Amin, Mahul; Brimo, Fadi; Grignon, David; Hansel, Donna; Hes, Ondra; Malavaud, Bernard; Reuter, Victor; van der Kwast, Theo.
Afiliação
  • Compérat E; Department of Pathology, Hopital Tenon, HUEP, Sorbonne University, Paris, France. evacomperat@gmail.com.
  • Babjuk M; Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Algaba F; Department of Pathology, Fundacio Puigvert, Barcelona, Spain.
  • Amin M; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Brimo F; Department of Urology, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Grignon D; McGill University Health Center, Glen Site, Office E4-4188, 1001 Decarie Blvd, Montréal, QC, H4A 3J1, Canada.
  • Hansel D; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, IUH Pathology Laboratory, Indianapolis, IN, USA.
  • Hes O; Departments of Pathology and Urology, University of California, San Diego, CA, USA.
  • Malavaud B; Charles University and University Hospital Plzen, Pilsen, Czech Republic.
  • Reuter V; Department of Urology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • van der Kwast T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
World J Urol ; 37(1): 41-50, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30218308
Many changes have been made during these last years and concepts for understanding bladder cancer have evolved. We make an update with the latest findings of the WHO (World Health Organistaion) 2016, ICCR (International Collaboration on Cancer Reporting) and other official organisms and try to show the latest developments. In this document we provide new consensus guidelines and insights. We kept this document short and concise providing consensus guidelines to clinicians for the best patient care, it should be easy to understand for a non pathologists. We focussed on several burning issues, such as the anatomical and histological understanding of the bladder wall, the prognostic significance of grading and the most challenging problems in staging, we underline our needs from the clinicians such as clinical information, we further discuss the histological subtypes of bladder cancer, which is an extremely important issue in the light of molecular classifications and give prognostic insights. Furthermore, we discuss the ICCR worldwide consensus reporting, urinary cytology with the Paris system and several issues such as frozen section specimen.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: World J Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: World J Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França